Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_024675.4(PALB2):c.3497_3498delGT(p.Gly1166AspfsTer23) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. G1166G) has been classified as Likely benign.
PALB2 (HGNC:26144): (partner and localizer of BRCA2) This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the stable intranuclear localization and accumulation of BRCA2. [provided by RefSeq, Jul 2008]
PALB2 Gene-Disease associations (from GenCC):
hereditary breast carcinoma
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 17 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-23603521-TAC-T is Pathogenic according to our data. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr16-23603521-TAC-T is described in CliVar as Pathogenic. Clinvar id is 143975.Status of the report is no_assertion_criteria_provided, 0 stars.